ArticleFrontiers in neuroscience2015

Inhibition of multidrug resistance protein 1 (MRP1) improves chemotherapy drug response in primary and recurrent glioblastoma multiforme.

Amanda Tivnan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.